Managing Director & Partner
Baiping Chen is leading Boston Consulting Group's Health Care practice in Greater China.
He has acquired extensive experience consulting in health care management and has served many multinational pharmaceutical and medtech companies and large local pharmaceutical companies.
Baiping has worked in the areas of corporate growth strategy, portfolio strategy, commercial model innovation, new business development, globalization and outbound M&A, organization design and capability development, and leadership development. In 2012, he contributed expertise to BCG’s report The 2012 BCG 50 Chinese Global Challengers: End of Easy Growth.
Before joining the firm in 2007, Baiping worked for Sanofi-Aventis, Mylan, and Eli Lilly and was responsible for marketing research and planning for new cardiovascular, diabetes, central nervous system, and urology products.
The report proposes nine key initiatives, based on an extensive study of six industries. The initiatives are applicable to companies with any sectorial background, covering the whole net zero transition to help companies reach net zero in their own businesses as well as in their value chains.
To achieve dual climate goals, the Chinese government needs to accelerate the transformation of key industries by focusing on green energy and green finance; financial institutions have a vital role to play in facilitating decarbonization; and companies are the main force in the development of green economy.
Our simulation of China’s climate-change pathways shows that it has economically attractive and socially viable pathways to achieve its decarbonization goals.